Karen Walton–Bowen
Clinical Research Associates(US)
Publications by Year
Research Areas
Asthma and respiratory diseases, Respiratory and Cough-Related Research, Autism Spectrum Disorder Research, Inhalation and Respiratory Drug Delivery, Genetics and Neurodevelopmental Disorders
Most-Cited Works
- → Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human α-L-iduronidase (laronidase)(2004)542 cited
- → Effects of STX209 (Arbaclofen) on Neurobehavioral Function in Children and Adults with Fragile X Syndrome: A Randomized, Controlled, Phase 2 Trial(2012)324 cited
- → A Multiple-dosing, Placebo-controlled Study of Budesonide Inhalation Suspension Given Once or Twice Daily for Treatment of Persistent Asthma in Young Children and Infants(1999)199 cited
- → Arbaclofen in fragile X syndrome: results of phase 3 trials(2017)180 cited
- → Budesonide enema for the treatment of active, distal ulcerative colitis and proctitis: A dose-ranging study(1998)177 cited
- → Adaptive behavior in autism: Minimal clinically important differences on the Vineland‐II(2017)169 cited
- → Arbaclofen in Children and Adolescents with Autism Spectrum Disorder: A Randomized, Controlled, Phase 2 Trial(2016)159 cited
- → Efficacy and safety of budesonide inhalation suspension (Pulmicort Respules) in young children with inhaled steroid–dependent, persistent asthma(1998)146 cited
- → Once-daily budesonide inhalation suspension for the treatment of persistent asthma in infants and young children(1999)142 cited
- → STX209 (Arbaclofen) for Autism Spectrum Disorders: An 8-Week Open-Label Study(2013)124 cited